Sun et al.6 have demonstrated that the greatest number of LCSCs (EPCAM+, CD13+, and CD44+) is found in the stiffer invasive front of the liver cancer tissue in a rat liver cancer model, thus indicating that stiffer liver cancer tissue (marginal part) is more suitable for potentiating the stemness of LCSCs. This evidence concerns the gene EPCAM and liver cancer.